Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
iShares Global Tech ETF
IXN
$8.43B
| $2.6M | ﹤0.01% |
46,302
-150
| -0.3% | -$8.07K |
|
|
ADVM
2427
DELISTED
Adverum Biotechnologies
ADVM
| $2.6M | ﹤0.01% |
74,348
+41,295
| +125% | +$2.22M |
|
2428
New York Times
NYT
$12.2B
| $2.6M | ﹤0.01% |
59,735
+6,736
| +13% | +$300K |
|
2429
Avnet
AVT
$7.29B
| $2.6M | ﹤0.01% |
64,882
+26,070
| +67% | +$1.12M |
|
2430
POSCO
PKX
$16B
| $2.6M | ﹤0.01% |
33,838
+27,828
| +463% | +$2.2M |
|
2431
OrthoPediatrics
KIDS
$536M
| $2.6M | ﹤0.01% |
41,057
+317
| +0.8% | +$18.2K |
|
2432
Rambus
RMBS
$10B
| $2.59M | ﹤0.01% |
109,083
+57,776
| +113% | +$1.16M |
|
|
RNAM
2433
DELISTED
Avidity Biosciences
RNAM
| $2.58M | ﹤0.01% |
104,627
+28,119
| +37% | +$654K |
|
2434
Rhythm Pharmaceuticals
RYTM
$7.05B
| $2.58M | ﹤0.01% |
131,899
-20,529
| -13% | -$426K |
|
2435
Hain Celestial
HAIN
$45.5M
| $2.58M | ﹤0.01% |
64,343
-191,306
| -75% | -$7.9M |
|
2436
Domo
DOMO
$184M
| $2.58M | ﹤0.01% |
31,862
-50,426
| -61% | -$3.3M |
|
2437
PUT
Paychex
PAYX
$41.9B
| $2.58M | ﹤0.01% |
24,000
| – | – |
|
2438
iShares MSCI USA Quality Factor ETF
QUAL
$47B
| $2.57M | ﹤0.01% |
19,372
-9,315
| -32% | -$1.19M |
|
2439
iShares Select U.S. REIT ETF
ICF
$2.1B
| $2.57M | ﹤0.01% |
39,364
-2,696
| -6% | -$169K |
|
|
BCPC
2440
Balchem Corp
BCPC
$5.58B
| $2.57M | ﹤0.01% |
19,573
+15,931
| +437% | +$2.05M |
|
2441
Sutro Biopharma
STRO
$416M
| $2.56M | ﹤0.01% |
13,760
-3,199
| -19% | -$626K |
|
2442
UMB Financial
UMBF
$11.2B
| $2.56M | ﹤0.01% |
27,474
+2,651
| +11% | +$252K |
|
2443
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$262M
| $2.56M | ﹤0.01% |
22,691
-256
| -1% | -$29.3K |
|
|
KDMN
2444
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.54M | ﹤0.01% |
657,314
-168,969
| -20% | -$655K |
|
2445
iShares MSCI Indonesia ETF
EIDO
$484M
| $2.54M | ﹤0.01% |
125,396
+23,543
| +23% | +$507K |
|
2446
Globus Medical
GMED
$11.1B
| $2.54M | ﹤0.01% |
32,745
-90,725
| -73% | -$6.45M |
|
|
RDUS
2447
DELISTED
Radius Health, Inc.
RDUS
| $2.54M | ﹤0.01% |
139,019
+15,325
| +12% | +$305K |
|
2448
Alaunos Therapeutics
TCRT
$4.66M
| $2.53M | ﹤0.01% |
6,393
+772
| +14% | +$360K |
|
2449
Fidelity Investment Grade Bond ETF
FIGB
$519M
| $2.52M | ﹤0.01% |
50,000
| – | – |
|
2450
Shift4
FOUR
$4.31B
| $2.52M | ﹤0.01% |
26,876
+23,033
| +599% | +$2.17M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.